However, there were no significant differences in the age, tumor size, FIGO stage, histological types, HPV and lymphatic metastasis between the PAX1 hypermethylated and PAX1 hypomethylated groups, suggesting that PAX1 methylation status may not be affected by other clinical factors. Here, PAX1 is linked to neoplasm.